VenoStent, Inc.
VenoStent is a venture backed, clinical stage medical device and tissue engineering company developing bioabsorbable wraps to transform outcomes in vascular surgery
VenoStent, Inc.
VenoStent, Inc. develops and researches SelfWrap, a bioabsorbable vascular wrap designed to improve dialysis access site outcomes for patients with chronic kidney disease.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Bioabsorbable materials
3D-printed polymers
Solutions to improve patency rates in hospitals and clinics performing AV access surgeries
Service Requirements
Training and support for surgeons using SelfWrap
Clinical trial support
Regulatory compliance consulting
Training on FCOI policies
Infrastructure Requirements
Manufacturing capacity for clinical and commercial supply of SelfWrap.
Requirements for GLP large animal testing and clinical trial execution.
3D printing equipment
Space for testing and innovating
Talent Requirements
Materials engineering expertise
Expertise in regulatory compliance for medical devices
Clinical trial management expertise
AI Insights
Growth Trajectory
VenoStent shows strong growth potential through the ongoing clinical trials, recent $16M Series A financing, and potential expansion into coronary and peripheral bypass grafting.
Market Opportunity
VenoStent has a significant market opportunity in addressing the high failure rate of dialysis access sites, which translates to substantial Medicare costs and patient quality of life improvements.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats